Comparing Ajovy vs Emgality
| Ajovy (fremanezumab) | Emgality (galcanezumab) |
|
|---|
| Ajovy (fremanezumab) | Emgality (galcanezumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Ajovy is a prescription medicine used to prevent migraine headaches that can be self-injected under the skin once a month or once every three months (using a higher dosage). Injection site reactions... View more |
Prescription only
Emgality is an injectable medication that can be self-administered subcutaneously (under the skin) once monthly for the prevention of migraine in adults or during a cluster headache period when used... View more |
Related suggestions Migraine Prevention (Migraine Prophylaxis)
Popular comparisons
|
|||||||||||||||
| More about Ajovy (fremanezumab) | More about Emgality (galcanezumab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Ajovy has an average rating of 5.6 out of 10 from a total of 337 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 39% reported a negative effect. |
Emgality has an average rating of 5.2 out of 10 from a total of 497 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Ajovy side effects |
View all Emgality side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Ajovy prices |
View all Emgality prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
744 hours |
648 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 2 drugs are known to interact with Ajovy:
|
A total of 2 drugs are known to interact with Emgality:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 14, 2018 |
September 27, 2018 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.